AMN107 (imatinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMN107 (imatinib), covering 2021-06-29 to 2021-06-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies [Phase 1, Phase 2]